LSC - 2024 - Novel SASP factor mediates fibroblast reprogramming in aging-associated pulmonary fibrosis
Melo Narvaez,M. C.,Jain,E.,Suciu,T.,Asgharpour,S.,Hu,Q.,Stoleriu,M.-G.,Cabeza-Boeddinghaus,N.,Staab-Weijnitz,C.,Burgstaller,G.,Yildirim,A. O.,Koenigshoff,M.,Lehmann,M.
DOI: https://doi.org/10.1183/13993003.congress-2024.oa5480
IF: 24.3
2024-11-01
European Respiratory Journal
Abstract:Senescent cells accumulate in aged and diseased lungs and their senescence-associated secretory phenotype (SASP) has been linked to the inflammation and impaired regeneration found in idiopathic pulmonary fibrosis (IPF). However, molecular targets to prevent or reverse senescence-mediated fibrotic changes are missing. Here, we aimed to identify SASP factors involved in aging-associated lung fibrosis using a novel clinically relevant ex vivo model. We irradiated human precision cut-lung slices (IR-hPCLS) to induce cellular senescence and used multiplex immunofluorescence, cytokine arrays, and bulk- and single-nuclei RNA-seq to characterize senescence-mediated fibrotic changes. IR-hPCLS exhibited hallmarks of premature aging, like alveolar epithelial cellular senescence, stem cell dysfunction, and inflammation, along with profibrotic changes and extracellular matrix remodeling. Senescence and downstream profibrotic changes of IR-hPCLS were reversed by senolytics. Longitudinal secretome analysis revealed a novel SASP factor, upregulated in the senescent alveolar epithelium of IR-hPCLS. Mechanistically, this secreted factor significantly induced primary human lung fibroblast activation in vitro and ex vivo, as shown by the upregulation of smooth Muscle Actin Alpha 2 (aSMA) and alpha-1 Type I Collagen (COL1A1) in a TGF-β1-dependent manner. Moreover, IPF lungs showed a significant increase in senescent cells (P16+) co-expressing this secreted protein in comparison to age-matched controls. In conclusion, we present a novel pro-fibrotic SASP factor involved in the epithelial-to-mesenchymal crosstalk in senescence-associated lung fibrosis as a potential therapeutical target or biomarker for IPF.
respiratory system